Search

Search Results

• A POPULATION-BASED STUDY ON MYELODYSPLASTIC SYNDROMES IN THE LAZIO REGION (ITALY), MEDICAL MISCODING AND 11-YEAR MORTALITY FOLLOW-UP: THE GRUPPO ROMANO-LAZIALE MIELODISPLASIE EXPERIENCE OF RETROSPECTIVE MULTICENTRIC REGISTRY

  Flavia Mayer, Laura Faglioni, Nera Agabiti, Susanna Fenu, Francesco Buccisano, Roberto Latagliata, Roberto Ricci, Maria Antonietta Aloe Spiriti, Caterina Tatarelli, Massimo Breccia, Giuseppe Cimino, Luana Fianchi, Svitlana Gumenyuk, Stefano Mancini, Luca Maurillo, Carolina Nobile, Pasquale Niscola, Anna Lina Piccioni, Agostino Tafuri, Giulio Trapè, Alessandro Andriani, Paolo De Fabritis, Maria Teresa Voso, Marina Davoli, Gina Zini

  e2017046

  2017-07-01

  https://doi.org/10.4084/mjhid.2017.046

  2731

  PDF: 1017

  HTML: 1115

• INFECTIOUS RISKS AND COMPLICATIONS IN ADULT LEUKEMIC PATIENTS RECEIVING BLINATUMOMAB

  Wonhee So, Shuchi Pandya, Rod Quilitz, John Greene

  e2018029

  2018-05-01

  https://doi.org/10.4084/mjhid.2018.029

  2895

  PDF: 1077

  HTML: 308

• How I treat acute and persistent sickle cell pain

  Samir Ballas

  e2020064

  2020-09-08

  https://doi.org/10.4084/mjhid.2020.064

  1980

  PDF: 1127

  HTML: 492

• HEMATOPOIETIC CELL TRANSPLANTATION FOR OLDER PATIENTS WITH MDS

  Mazyar Shadman, Joachim Deeg

  e2014056

  2014-09-01

  https://doi.org/10.4084/mjhid.2014.056

  2049

  PDF: 774

  HTML: 3118

• HHVs AND LYMPHOPROLIFERATIVE DISORDERS

  C Quadrelli, P Barozzi, G Riva, Mario Luppi

  e2011043

  2011-10-24

  https://doi.org/10.4084/mjhid.2011.043

  1426

  PDF: 831

  HTML: 3124

• SUSTAINED REMISSION IN AN ELDERLY PATIENT WITH ACUTE MYELOID LEUKEMIA FOLLOWING GILTERITINIB TREATMENT AS THIRD-LINE SALVAGE THERAPY Long-lasting disease remission with third line therapy with gilteritinib

  Matteo Molica

  e2024079

  2024-10-31

  https://doi.org/10.4084/MJHID.2024.079

  961

  PDF: 524

  HTML: 216

• Is there a better therapeutic time window from diagnosis to treatment elderly acute myeloid leukemia patients receiving hypomethylating agents?

  Salvatore Perrone

  e2024055

  2024-06-29

  https://doi.org/10.4084/MJHID.2024.055

  591

  PDF: 813

  HTML: 103

• EVALUATION OF USING EMPIRIC GLYCOPEPTIDES IN ACCORDANCE WITH THE IDSA GUIDELINE IN HEMATOLOGIC MALIGNANCY PATIENTS WITH FEBRILE NEUTROPENIA Empiric glycopeptide use in neutropenic fever

  Cumali Yalçın, Fahir Özkalemkaş, Vildan Özkocaman, Tuba Ersal, İbrahim Ethem Pınar, Bedrettin Orhan, Ömer Candar, Sinem Çubukçu, Tuba Güllü Koca, Merve Nur Akyol, Nevriye Gül Ada, Cüneyt Özakın, Esra Kazak, Halis Akalın, Rıdvan Ali

  e2022039

  2022-04-28

  https://doi.org/10.4084/MJHID.2022.039

  1522

  PDF: 1089

  HTML: 223

• HOW I TREAT NEWLY DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA

  Giuseppe Avvisati

  e2011064

  2011-12-19

  https://doi.org/10.4084/mjhid.2011.064

  13296

  PDF: 990

  HTML: 7297

• WHO HAS THERAPY-RELATED AML?

  Robert Gale, John M. Bennett, F. Owen Hoffman

  e2017025

  2017-03-01

  https://doi.org/10.4084/mjhid.2017.025

  3150

  PDF: 4323

  HTML: 809

• A case of atypical prolonged hematologic toxicity with azacitidine in Chronic Myelomonocytic Leukemia (CMML), review of literature and a proposal of management

  Elena Elli, Caterina Cecchetti, Angelo Belotti, Lorenza Borin, Enrico Maria Pogliani

  e2012017

  2012-03-13

  https://doi.org/10.4084/mjhid.2012.017

  1227

  PDF: 660

  HTML: 759

• Clinical and Prognostic Features in a Young Adult Patient with de novo Myelodysplastic Syndrome presenting t(11;16) (q23; q24)

  Viviane Lamim Lovatel, Luize Otero, Ercole Pietro Orlando, Claudia Diniz, Filipe Vicente dos Santos-Bueno, Bruno Almeida Lopes, Elaiza Almeida Antônio de Kós, Monica Kopischitz Praxedes Lusis, Eliana Abdelhay, Teresa de Souza Fernandez

  e2022013

  2022-01-01

  https://doi.org/10.4084/MJHID.2022.013

  1146

  PDF: 566

  HTML: 226

• FLUDARABINE-BASED LOW-INTENSITY CONDITIONING FOR FANCONI ANEMIA IS ASSOCIATED WITH GOOD OUTCOMES IN APLASTIC ANEMIA BUT NOT IN MDS - A SINGLE-CENTER EXPERIENCE

  Biju George, Sohini Chattopadhyay, Sharon Lionel, Sushil Selvarajan, Anup Devasia, Anu Korula, Uday Kulkarni, Fouzia Aboobacker, Eunice Sindhuvi, Kavitha Lakshmi, Alok Srivastava, Aby Abraham, Vikram Mathews

  e2023039

  2023-06-29

  https://doi.org/10.4084/MJHID.2023.039

  1353

  PDF: 1018

  HTML: 330

• ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR ADULT PATIENTS WITH FANCONI ANEMIA.

  hosein kamranzadeh fumani, Mohammad Zokaasadi, Amir Kasaeian, Kamran Alimoghaddam, Asadollah Mousavi, Babak Bahar, Mohammad Vaezi, Ardeshir Ghavamzadeh

  e2016054

  2016-11-01

  https://doi.org/10.4084/mjhid.2016.054

  3965

  PDF: 883

  HTML: 737

• COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.

  Federico Mercolini, Simone Cesaro

  e2022009

  2022-01-01

  https://doi.org/10.4084/MJHID.2022.009

  2548

  PDF: 954

  HTML: 306

• AZACITIDINE IN CHRONIC MYELOMONOCYTIC LEUKEMIA: AN EFFECTIVE AND MANAGEABLE APPROACH.

  Pasquale Niscola

  e2014020

  2014-02-16

  https://doi.org/10.4084/mjhid.2014.020

  1681

  PDF: 905

  HTML: 2787

• Hemophagocytic lymphohistiocytosis secondary to refractory acute myeloid leukemia resolved after second line treatment with azacitidine plus venetoclax

  Claudio Fozza

  e2024011

  2024-01-01

  https://doi.org/10.4084/MJHID.2024.011

  1670

  PDF: 1374

  HTML: 184

• Hematogenous Disseminated Pulmonary Tuberculosis in an Elderly Patient with Acute Myeloid Leukemia: A Case Report

  Yu xi Ding, Xiao Dong Liu, wenqiang kong

  e2026010

  2026-01-01

  https://doi.org/10.4084/MJHID.2026.010

  610

  PDF: 517

  HTML: 219

• ANTIBIOTIC LOCK THERAPY FOR PORT CATHETER-RELATED INFECTIONS OF CHILDREN WITH ACUTE LEUKEMIA

  Burçin Kurtipek; Ayça Koca Yozgat, Saliha Kanık Yüksek, Dilek Kaçar, Turan Bayhan, Dilek Gürlek Gökçebay, Aslınur Özkaya Parlak, Neşe Yaralı

  e2024072

  2024-08-31

  https://doi.org/10.4084/MJHID.2024.072

  2016

  PDF: 1041

  HTML: 288

• HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THALASSEMIA AND SICKLE CELL DISEASE: EXPERIENCE OF MEDITERRANEAN INSTITUTE OF HEMATOLOGY IN A MULTI-ETHNIC POPULATION.

  Marco Marziali, Antonella Isgrò, Javid Gaziev, Guido Lucarelli

  e2009027

  2009-12-26

  1712

  PDF: 731

  HTML: 2922

• 5-Azacytidine in chronic myelomonocytic leukemia: case report and review of literature

  Mariangela Greco, Marianna Criscuolo, Luana Fianchi, Livio Pagano, Maria Teresa Voso

  e2011011

  2011-03-14

  https://doi.org/10.4084/mjhid.2011.011

  1636

  PDF: 770

  HTML: 1118

• RECENT ADVANCES IN THE 5Q- SYNDROME

  Andrea Pellagatti, Jacqueline Boultwood

  e2015037

  2015-05-20

  https://doi.org/10.4084/mjhid.2015.037

  2820

  PDF: 1841

  HTML: 3688

  Pellagatti Fig 1: 223

  Pellagatti Fig. 2: 217

• miR-155-5p PROMOTES CD34+ APOPTOSIS AND INHIBITS BONE MARROW HEMATOPOIESIS IN MYELODYSPLASTIC SYNDROMES BY RAC1/CREB/MIR-15B AXIS

  Meiwan Cao, BaoLing Peng, WanFu Xu, PeiYu Chen, Huan Chen, LiPing Ye, Jing Xie, HongLi Wang, Lu Ren, LiYa Xiong, JingNan Zhu, XiangYe Xu, LanLan Geng, SiTang Gong

  e2023040

  2023-06-29

  https://doi.org/10.4084/MJHID.2023.040

  755

  PDF: 881

  PDF Supp. Files: 79

  HTML: 193

• HEMATOLOGY PATIENT PROTECTION DURING THE COVID-19 PANDEMIC IN ITALY: A NATIONWIDE NURSING SURVEY Hematology patient protection during the COVID-19

  Stefano Botti, Nicola Serra, Fausto Castagnetti, Sabina Chiaretti, Nicola Mordini, Gianpaolo Gargiulo, Laura Orlando

  e2021011

  2021-01-01

  https://doi.org/10.4084/mjhid.2021.011

  1650

  PDF: 597

  HTML: 236

• Isavuconazole therapy of disseminated and encephalic Saprochaete capitata infection in an acute myeloid leukemia patient treated with midostaurin.

  Salvatore Perrone, Chiara Lisi, Elettra Ortu La Barbera, Cristina Luise, Miriam Lichtner, Corrado Girmenia, Giuseppe Cimino

  e2020026

  2020-04-27

  https://doi.org/10.4084/mjhid.2020.026

  1519

  PDF: 818

  HTML: 338

• ANTIFUNGAL PROPHYLAXIS IN IMMUNOCOMPROMISED PATIENTS

  Lourdes Vazquez

  e2016040

  2016-09-01

  https://doi.org/10.4084/mjhid.2016.040

  4355

  PDF: 1390

  HTML: 2052

• NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES

  Francesco D'Alò, Mariangela Greco, Marianna Criscuolo, Maria Teresa Voso

  e2010021

  2010-08-11

  https://doi.org/10.4084/mjhid.2010.021

  2001

  PDF: 790

  HTML: 702

• ROLE AND TIMING OF HEMATOPOIETIC CELL TRANSPLANTATION FOR MYELODYSPLASTIC SYNDROME

  Teresa L Field, Claudio Anasetti

  e2010019

  2010-07-19

  https://doi.org/10.4084/mjhid.2010.019

  1372

  PDF: 681

  HTML: 1187

• Acquired Sideroblastic Anemia: An exploratory Comparative Statistical Analysis Between Clonal and Non-clonal cases Acquired Sideroblastic Anemia

  Dina Sameh Soliman, Samah Kohla, Shehab Fareed, Susanna Akiki , Aliaa Amer, Ibrahim Ganwo, Prem Chandra, Halima El-Omri, Feryal Ibrahim

  e2022067

  2022-08-27

  https://doi.org/10.4084/MJHID.2022.067

  995

  PDF: 603

  HTML: 403

• Fusion Gene Landscape in a Case of Acute Myelocytic Leukemia with Myelocyte Morphology

  Zhan Su, Yan Li, Haidong Zhu, Yaqi Wang, Meiying Yang

  e2025004

  2024-12-31

  https://doi.org/10.4084/MJHID.2025.004

  1210

  PDF: 1021

  HTML: 183

• Extending Long Term Follow-up of Patient With Acute Myeloid Leukemia after Autologous Stem Cell Transplantation: disclosing late mortality and causes of death.

  Federica Sorà, Patrizia Chiusolo, luca laurenti, idanna innocenti, francesco autore, andrea corbingi, andrea corbingi, sabrina giammarco, elisabetta metafuni, andrea bacigalupo, simona sica

  e2020030

  2020-04-27

  https://doi.org/10.4084/mjhid.2020.030

  1443

  PDF: 626

  HTML: 206

• ANORECTAL COMPLICATIONS DURING NEUTROPENIC PERIOD IN PATIENTS WITH HEMATOLOGIC DISEASES

  Soner Solmaz

  e2016019

  2016-03-01

  https://doi.org/10.4084/mjhid.2016.019

  3052

  PDF: 986

  HTML: 1570

• COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR Infection With PTCy Versus Standard GvHD Prophylaxis

  Selim SAYIN

  e2024016

  2024-02-29

  https://doi.org/10.4084/MJHID.2024.016

  1436

  PDF: 1329

  HTML: 103

• Successful treatment of de novo acute myeloid leukaemia associated aortitis by induction chemotherapy alone

  Urbain Tauveron--Jalenques, Vincent Grobost, Benoît Magnin, Cécile Moluçon-Chabrot, Jacques-Olivier Bay, Olivier Tournilhac; Romain Guièze

  e2024025

  2024-02-29

  https://doi.org/10.4084/MJHID.2024.025

  671

  PDF: 1081

  HTML: 117

• THE ROLE OF WHITE BLOOD CELL COUNT IN PERIANAL PATHOLOGIES: A RETROSPECTIVE ANALYSIS OF HEMATOLOGIC MALIGNANCIES Role of white blood cell count in perianal pathologies

  Bedrettin Orhan, Fahir Özkalemkaş, Vildan Özkocaman, Büşra Gürbüz, Tuba Ersal, İbrahim Ethem Pınar, Cumali Yalçın, Ömer Candar, Sinem Çubukçu, Tuba Güllü Koca, Rıdvan Ali

  e2022051

  2022-06-29

  https://doi.org/10.4084/MJHID.2022.051

  3789

  PDF: 1942

  HTML: 245

• The THE PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW: PART 2-FOCUS ON THERAPY

  Michele Bibas

  e2024015

  2024-02-29

  https://doi.org/10.4084/MJHID.2024.015

  1819

  PDF: 1691

  HTML: 901

• Pseudo-differentiation syndrome

  Dina Khalaf, Fathi Jehani

  e2011061

  2011-12-15

  https://doi.org/10.4084/mjhid.2011.061

  1386

  PDF: 672

  HTML: 10852

  Figure 1: peripheral blood showing myeloblasts with auer rods: 120

  Figure 2: CXR upon presentation to the hospital- no infiltrates nor consolidation changes: 105

  Figure 3: CXR showing pulmonary infiltartes with consolidation: 137

  Figure 4: CXR after starting steroid therapy- where the infiltrates have melted away: 118

  Figure 5: barograph showing the rising TLC ad ANC values- associated with worsening symptoms and increasing pulmonary infiltrates in CXR: 119

• Complete Remission Obtained with Azacitidine in a Patient with Concomitant Therapy Related Myeloid Neoplasm and Pulmonary Mucormycosis

  Saveria Capria, Federico De Angelis, Giuseppe Gentile, Silvia Maria Trisolini, Simonetta Brocchieri, Martina Canichella, Patrizia Chiusolo, Alessandra Micozzi, Robin Foà, Giovanna Meloni

  e2013048

  2013-07-10

  https://doi.org/10.4084/mjhid.2013.048

  1580

  PDF: 691

  HTML: 1916

• The significance of purity: Leukaemias involving the erythroid lineage Erythroid lineage leukemia

  Prof. Vincenzo Liso, Prof. Arcangelo Liso, Prof. Gina Zini

  e2020077

  2020-10-27

  https://doi.org/10.4084/mjhid.2020.077

  831

  PDF: 426

  HTML: 301

• ORAL/ENTERAL NUTRITIONAL SUPPLEMENTATION IN CHILDREN TREATED FOR CANCER IN LOW-MIDDLE-INCOME COUNTRIES IS FEASIBLE AND EFFECTIVE: THE EXPERIENCE OF THE CHILDREN'S HOSPITAL MANUEL DE JESUS RIVERA "LA MASCOTA" IN NICARAGUA.

  Nicolò Peccatori, Roberta Ortiz, Emanuela Rossi, Patricia Calderon, Valentino Conter, Yesly Garcia, Andrea Biondi, Darrel Espinoza, Francesco Ceppi, Luvy Mendieta, Maria Luisa Melzi

  e2018038

  2018-06-23

  https://doi.org/10.4084/mjhid.2018.038

  7561

  PDF: 878

  HTML: 367

• INFECTIOUS COMPLICATIONS AFTER UMBILICAL CORD-BLOOD TRANSPLANTATION FROM UNRELATED DONORS

  Juan Montoro, Jaime Sanz

  e2016051

  2016-10-18

  https://doi.org/10.4084/mjhid.2016.051

  3371

  PDF: 999

  HTML: 1469

• COMPARATIVE EVALUATION OF BONE MARROW ASPIRATE WITH TREPHINE BIOPSY IN HEMATOLOGICAL DISORDERS AND DETERMINATION OF OPTIMUM TREPHINE LENGTH IN LYMPHOMA INFILTRATION

  Surbhi Goyal, Usha Rani Singh, Usha Rusia

  e2014002

  2013-12-31

  https://doi.org/10.4084/mjhid.2014.002

  2009

  PDF: 1077

  HTML: 51809

• Managment of Relapsed/Refractory ALL With Inotuzumab During COVID-19. A Casr Report

  Martina Di Palma, Elio Gentilini, Chiara Masucci, Alessandra Micozzi, Ombretta Turriziani, Antonino Mulè, Robin Foà, Maurizio Martelli, Gabriella D'Ettorre, Saveria Capria, Sabina Chiaretti

  e2022043

  2022-04-28

  https://doi.org/10.4084/MJHID.2022.043

  1374

  PDF: 593

  HTML: 226

• REFRACTORY THROMBOCYTOPENIA AND NEUTROPENIA: A DIAGNOSTIC CHALLENGE

  Emmanuel Gyan, François Dreyfus, Pierre Fenaux

  e2015018

  2015-02-13

  https://doi.org/10.4084/mjhid.2015.018

  12428

  PDF: 1687

  HTML: 4216

  Cover letter: 205

  Figure 1: 213

• DETECTION OF CALR MUTATIONS USING HIGH RESOLUTION MELTING CURVE ANALYSIS (HRM-A); APPLICATION ON A LARGE COHORT OF GREEK ET AND MF PATIENTS

  Andreas Giannopoulos, Niki Rougkala, Theodoros Loupis, Marina Mantzourani, Nora-Athina Viniou, Eleni Variami, Theodoros Vassilakopoulos, George Dryllis, Ioannis Kotsianidis, Theodora Gougopoulou, Marianna Politou, Konstantinos Konstantopoulos, George Vassilopoulos

  e2019009

  2019-01-01

  https://doi.org/10.4084/mjhid.2019.009

  3068

  PDF: 1222

  HTML: 545

• SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis

  Roberta Zanotti, Massimiliano Bonifacio, Ilaria Tanasi, Donatella Schena, Giovanni Orsolini, Morena Tebaldi, Lara Crosera, Francesca Mastropaolo, Elisa Olivieri, Dr. Patrizia Bonadonna

  e2021068

  2021-10-29

  https://doi.org/10.4084/MJHID.2021.068

  1590

  PDF: 1046

  HTML: 238

• TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin

  Cristina Papayannidis, Vincenzo Federico, Luana Fianchi, Patrizia Pregno, Novella Pugliese, Alessandra Romano, Federica Irene Grifoni

  e2022073

  2022-10-29

  https://doi.org/10.4084/MJHID.2022.073

  1278

  PDF: 1018

  HTML: 226

• A case of central venous catheter-related Candida parapsilosis fungemia evolved to disseminated infection in a neutropenic patient with blast crisis of chronic myeloid leukemia.

  Elena Amabile, Matteo Totaro, Luca Cappelli, Clara Minotti, Alessandra Micozzi

  e2024013

  2024-01-01

  https://doi.org/10.4084/MJHID.2024.013

  969

  PDF: 1177

  HTML: 166

• Low incidence of anti-pf4/heparin antibodies in patients with acute myelogenous leukemia.

  Håkon Reikvam, Ingvild Jenssen Lægreid, Ingvild Hausberg Sørvoll, Tom Sollid, Trude Victoria Mørtberg, Maria Therese Ahlén, Silje Johansen

  e2024057

  2024-06-29

  https://doi.org/10.4084/MJHID.2024.057

  953

  PDF: 879

  HTML: 152

• PERIPHERAL NERVOUS SYSTEM INVOLVEMENT IN LYMPHOPROLIFERATIVE DISORDERS

  Mario Sabatelli, Luca Laurenti, Marco Luigetti

  e2018057

  2018-09-01

  https://doi.org/10.4084/mjhid.2018.057

  1782

  PDF: 885

  HTML: 386

  Fig1: 240

  Fig.2: 259

  Fig. 3: 191

  Fig. 5: 205

  Fig. 4: 231